Correlation Between NYSE Composite and ARCA Biopharma

Can any of the company-specific risk be diversified away by investing in both NYSE Composite and ARCA Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and ARCA Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NYSE Composite and ARCA Biopharma, you can compare the effects of market volatilities on NYSE Composite and ARCA Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of ARCA Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and ARCA Biopharma.

Diversification Opportunities for NYSE Composite and ARCA Biopharma

-0.16

Correlation Coefficient

NYSE Composite  ARCA Biopharma

Good diversification

The 3 months correlation between NYSE and ARCA is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and ARCA Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ARCA Biopharma and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with ARCA Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ARCA Biopharma has no effect on the direction of NYSE Composite i.e., NYSE Composite and ARCA Biopharma go up and down completely randomly.

Pair Corralation between NYSE Composite and ARCA Biopharma

If you would invest (100.00) in ARCA Biopharma on September 26, 2024 and sell it today you would earn a total of  100.00  from holding ARCA Biopharma or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

NYSE Composite  vs.  ARCA Biopharma

Pair Trading with NYSE Composite and ARCA Biopharma

The main advantage of trading using opposite NYSE Composite and ARCA Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, ARCA Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARCA Biopharma will offset losses from the drop in ARCA Biopharma's long position.

The idea behind NYSE Composite and ARCA Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.